Oncology Corporate Profile
Cancer Prevention Pharmaceuticals, Inc. is developing novel therapeutic agents, diagnostics, and lifestyle recommendations that make possible the treatment of risk factors for cancer. Our clinical focus is in familial adenomatous polyposis, neuroblastoma and the prevention of recurrence in colon cancer survivors. However, CPP also has therapeutic prevention approaches for prostate cancer, breast cancer, and skin cancers which will be developed together with the National Cancer Institute (as resources become available in the future) and multiple academic partners.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|CPP-1X||adenoma therapy||Colorectal cancer||III|
|CPP-1X||adenoma therapy||Gastric cancer||II|